GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Shanghai Xuerong Bio-Technology Co Ltd (SZSE:300511) » Definitions » Debt-to-Equity

Shanghai Xuerong Bio-Technology Co (SZSE:300511) Debt-to-Equity : 1.80 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Shanghai Xuerong Bio-Technology Co Debt-to-Equity?

Shanghai Xuerong Bio-Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,141 Mil. Shanghai Xuerong Bio-Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,661 Mil. Shanghai Xuerong Bio-Technology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,561 Mil. Shanghai Xuerong Bio-Technology Co's debt to equity for the quarter that ended in Mar. 2024 was 1.80.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shanghai Xuerong Bio-Technology Co's Debt-to-Equity or its related term are showing as below:

SZSE:300511' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.62   Med: 0.98   Max: 1.8
Current: 1.8

During the past 13 years, the highest Debt-to-Equity Ratio of Shanghai Xuerong Bio-Technology Co was 1.80. The lowest was 0.62. And the median was 0.98.

SZSE:300511's Debt-to-Equity is ranked worse than
91.67% of 1645 companies
in the Consumer Packaged Goods industry
Industry Median: 0.41 vs SZSE:300511: 1.80

Shanghai Xuerong Bio-Technology Co Debt-to-Equity Historical Data

The historical data trend for Shanghai Xuerong Bio-Technology Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Xuerong Bio-Technology Co Debt-to-Equity Chart

Shanghai Xuerong Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.97 1.19 1.01 1.44

Shanghai Xuerong Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.95 1.35 1.44 1.80

Competitive Comparison of Shanghai Xuerong Bio-Technology Co's Debt-to-Equity

For the Farm Products subindustry, Shanghai Xuerong Bio-Technology Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Xuerong Bio-Technology Co's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Shanghai Xuerong Bio-Technology Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shanghai Xuerong Bio-Technology Co's Debt-to-Equity falls into.



Shanghai Xuerong Bio-Technology Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shanghai Xuerong Bio-Technology Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shanghai Xuerong Bio-Technology Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Xuerong Bio-Technology Co  (SZSE:300511) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Shanghai Xuerong Bio-Technology Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shanghai Xuerong Bio-Technology Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Xuerong Bio-Technology Co (SZSE:300511) Business Description

Traded in Other Exchanges
N/A
Address
No 999 Gaofeng Road, Modern Agriculture Park, Fengxian District, Shanghai, CHN, 201401
Shanghai Xuerong Bio-Technology Co Ltd is a bio-agricultural company, engages in the research, production, and marketing of edible fungi primarily in the People's Republic of China. It offers various mushroom products, such as white enoki, white-shimeji, brown-shimeji, seafood mushroom, king crab mushroom, king oyster mushroom, pleurotus nebrodensis, agaricus bisporus, and shiitake.

Shanghai Xuerong Bio-Technology Co (SZSE:300511) Headlines

No Headlines